Magrolimab Recruiting Phase 2 Trials for Metastatic Colorectal Cancer (CRC) Treatment

Indications	Status	Purpose	Phase
DBCOND0134580 (Metastatic Colorectal Cancer (CRC))	Recruiting	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT05330429	Study of Magrolimab Given Together With FOLFIRI/BEV in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)	Bevacizumab (DB00112) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Magrolimab (DB16225)